Biotech News
miRecule Partners with GBI Biomanufacturing to Advance ARC Therapies
miRecule, a biotechnology company developing RNA-based therapies, has announced a new strategic partnership with GBI Biomanufacturing, a contract development and manufacturing organisation (CDMO), to accelerate the development and clinical supply of its innovative Antibody-RNA Conjugate (ARC) therapies. The collaboration aims to
29 January 2025
Stay ahead of trends and best practices
